Scarica l'app Stockscreener
3.10
5.02%
0.1483
Marker Therapeutics Inc Azioni (MRKR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
17.75%
1.2441
|
1.0565 | 0.2576 | 0.7627 | 4.7343 |
Operating Expenses
|
5.04%
3.7931
|
3.9943 | 3.4577 | 4.8967 | 9.7866 |
| Benefits Costs and Expenses |
4.12%
3.6369
|
3.793 | 3.2396 | 4.8616 | 9.7019 |
| Costs And Expenses |
4.12%
3.6369
|
3.793 | 3.2396 | 4.8616 | 9.7019 |
| Operating Income/Loss |
13.23%
-2.549
|
-2.9378 | -3.20 | -4.1341 | -5.0522 |
| Income/Loss From Continuing Operations Before Tax |
12.56%
-2.3928
|
-2.7365 | -2.982 | -4.099 | -4.9676 |
| Income/Loss From Continuing Operations After Tax |
12.67%
-2.3928
|
-2.7401 | -2.982 | -4.099 | -4.9676 |
|
Net Income/Loss
|
14.64%
-2.3928
|
-2.8031 | -2.982 | 2.5158 | -4.9676 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
32,819%
8.902
|
0.027 | 8.8259 | 8.799 | 8.721 |
| Diluted Average Shares |
35,524%
8.902
|
-0.0251 | 8.8259 | 8.799 | 8.721 |
| Basic Earnings Per Share |
15.62%
-0.27
|
-0.32 | -0.34 | 0.29 | -0.57 |
| Diluted Earnings Per Share |
15.62%
-0.27
|
-0.32 | -0.34 | 0.29 | -0.57 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.89%
2.08%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):